AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Role of Contraception for the Dermatologist

Description

The presentation emphasizes the importance of dermatologists not only discussing contraception with patients but also prescribing it. Many patients turn to dermatologists for contraceptive options, especially if they are concerned about acne or side effects. It’s highlighted that nearly 50% of pregnancies are unintended, making it essential for healthcare providers to initiate conversations about contraception. The speaker discusses various contraceptive methods, such as oral contraceptives (OCs), patches, and rings, explaining the roles of hormones and the significance of patient-centered care in choosing the right method. Low-dose pills may have side effects, such as unscheduled bleeding, which can lead to discontinuation, so switching doses may improve patient experience. The importance of emergency contraception options like Plan B and Ella is also mentioned, along with their accessibility through prescriptions. The presentation touches on long-acting reversible contraception methods like IUDs and emphasizes their effectiveness and potential side effects. Resources such as bedsider.org are suggested for patient education. Adverse events associated with contraceptive use, including blood clots, are noted, stressing careful counseling on risks. Lastly, the US Medical Eligibility Criteria (USMEC) app is introduced to help assess contraceptive safety based on individual medical conditions, reinforcing the idea that the responsibility for discussing and managing birth control options extends into dermatology.

View more

Conclusions

  • Dermatologists should not only discuss contraception with patients but also feel comfortable prescribing it.
  • Approximately 50% of pregnancies in the U.S. are unintended, highlighting the importance of discussing birth control options with patients.
  • Different contraceptive methods vary significantly in effectiveness and patient-centered preferences are crucial in their selection.
  • Emergency contraception should always be considered and prescribed when appropriate, as it can be accessed through insurance.
  • When choosing a contraceptive method, healthcare providers should consider the potential impact on conditions like acne, as well as weight gain and other side effects.
  • Short acting methods like the pill, patch, and ring should be tailored to fit the individual patient's needs and experiences.
  • Lowering estrogen dosage in oral contraceptives has led to improved safety over the years with fewer side effects.
  • Patient education and involvement in choosing a contraceptive method is key to improving compliance and satisfaction with the chosen method.
  • Clinical guidelines such as the USMEC can assist in determining the suitability of various contraceptive methods based on a patient's medical history and conditions.
  • There is a need for continuous follow-up and reassessment of the contraceptive choice to ensure ongoing suitability for the patient.
  • Finer LB, et al. Unintended Pregnancy in the United States: A New Look at the Numbers. 2006.
  • Trussell J. In: Contraceptive Technology. 19th rev ed. 2007.
  • Crenin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2006; 108:1087-97.
  • Glasier AF, Cameron ST, Fine FM, et al. Ulipristal acetate versus levonorgestrel regimen of emergency contraception: a randomized non-inferiority trial and meta-analysis. Lancet. 2010; 375:555-62.
  • Hampton RM, et al. Contraception. 2001;63:289-95.
  • van Vliet HA, et al. Cochrane Database Syst Rev. 2006;3:CD003553.
  • Westoff C, et al. Contraception. 2002;66:141-145; Lara-Torre E, et al. Contraception. 2002;66:81-85.
  • Hatcher R, et al, eds. Contraceptive Technology. 2004.
  • Abrams LS, et al. J Clin Pharmacol. 2001;41:1232-1237, 1301-1309; Abrams LS, et al. Contraception. 2001;64:287-294; Creasy GW, et al. Semin Reprod Med. 2001;19:373-380; Audet MC, et al. JAMA. 2001;285:2347-2354; Smallwood GH, et al. Obstet Gynecol. 2001;98:799-805.
  • Wilks C, et al. Ann Pharmacother. 2003;37:912.
  • Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004425. doi: 10.1002/14651858.CD004425.pub6.